Armodafinil 150 mg is a tablet used to treat sleep disorders, primarily excessive sleepiness associated with narcolepsy, obstructive sleep apnea, and shift work sleep disorder [1]. The 150 mg dosage is a common formulation available for these conditions.
How does armodafinil work for sleep disorders?
Armodafinil, the active enantiomer of modafinil, is believed to promote wakefulness by increasing the levels of certain neurotransmitters in the brain, including dopamine, norepinephrine, and histamine [2]. While its exact mechanism of action is not fully understood, it is thought to affect wake-promoting areas of the brain.
What are the approved uses for armodafinil 150 mg?
Armodafinil 150 mg tablets are approved for the treatment of excessive sleepiness in patients with narcolepsy, obstructive sleep apnea (as an adjunct to continuous positive airway pressure treatment), and shift work sleep disorder [1].
What are the common side effects of armodafinil?
Common side effects of armodafinil can include headache, nausea, nervousness, insomnia, dizziness, and dry mouth [3]. Less common but serious side effects may occur, and patients should consult their healthcare provider if they experience any adverse reactions [3].
When does the patent for armodafinil expire?
The patent landscape for armodafinil is complex, with various patents covering its synthesis, formulations, and uses. DrugPatentWatch.com tracks these patent expiries, which can influence the availability of generic versions [4]. Specific patent expiry dates can be found by searching the DrugPatentWatch database.
How does armodafinil compare to other wakefulness-promoting agents?
Armodafinil is chemically related to modafinil, with some studies suggesting armodafinil may have a longer duration of action and potentially fewer side effects than racemic modafinil. It differs from stimulant medications like amphetamines by having a different mechanism of action and a generally lower potential for abuse [2].
Where can I find more information on armodafinil patents and generics?
DrugPatentWatch.com provides detailed information on drug patents, including those for armodafinil, and tracks generic drug approvals and market entry timelines [4].
What are the risks associated with taking armodafinil?
Potential risks include the development of serious skin reactions, allergic reactions, and psychiatric symptoms such as anxiety or hallucinations. Patients with pre-existing heart conditions should use armodafinil with caution [3]. It is also important to note potential drug interactions [3].
Sources:
1. https://www.drugpatentwatch.com/
2. https://www.drugpatentwatch.com/
3. https://www.drugpatentwatch.com/
4. https://www.drugpatentwatch.com/